Literature DB >> 10573164

Temporal mapping of transcripts in human herpesvirus-7.

Paola Menegazzi1, Monica Galvan1, Antonella Rotola1, Tullia Ravaioli1, Arianna Gonelli1, Enzo Cassai1, Dario Di Luca1.   

Abstract

Transcription of human herpesvirus-7 (HHV-7) in cultures of productively infected T-cells was studied. Transcription of HHV-7 was regulated by the typical herpesvirus cascade in which alpha, beta and gamma genes are sequentially transcribed. Transcripts of U10, U14, U18, U31, U39, U41, U42, U53, U73 and U89/90 were detected 3 h after infection and were not inhibited by the absence of protein synthesis and therefore were alpha functions. U19 and U18/20 were beta genes; their transcription was inhibited by cycloheximide but not by phosphonoacetate, an inhibitor of DNA synthesis. U60/66 and U98/100 were gamma genes since their spliced transcripts were not detected in cells treated with phosphonoacetate. HHV-7 transcription was regulated by complex mechanisms, which involve the temporal coordinated activation of specific viral promoters and post-transcriptional processing. Splice mechanisms were also temporally regulated. Transcription of U89/90 pre-mRNA and splice took place simultaneously in the immediate-early phase. On the other hand, U16/17 pre-mRNA was synthesized with typical alpha kinetics, but the spliced product was regulated as a beta function. Likewise, the primary transcripts of U60/66 and U98/100 were alpha and beta, respectively, but both spliced products were synthesized in the late phase of virus replication. Finally, HHV-7 supported a bona fide latent infection in the adult population, since viral transcripts were not detected in peripheral blood mononuclear cells of healthy donors infected with HHV-7.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573164     DOI: 10.1099/0022-1317-80-10-2705

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  New genes from old: redeployment of dUTPase by herpesviruses.

Authors:  Andrew J Davison; Nigel D Stow
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

2.  Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis.

Authors:  Elisabetta Caselli; Maria Chiara Zatelli; Roberta Rizzo; Sabrina Benedetti; Debora Martorelli; Giorgio Trasforini; Enzo Cassai; Ettore C degli Uberti; Dario Di Luca; Riccardo Dolcetti
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

3.  Complete Unique Genome Sequence, Expression Profile, and Salivary Gland Tissue Tropism of the Herpesvirus 7 Homolog in Pigtailed Macaques.

Authors:  Jeannette P Staheli; Michael R Dyen; Gail H Deutsch; Ryan S Basom; Matthew P Fitzgibbon; Patrick Lewis; Serge Barcy
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

4.  Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection.

Authors:  Simone Avanzi; Valerio Leoni; Antonella Rotola; Francesco Alviano; Liliana Solimando; Giacomo Lanzoni; Laura Bonsi; Dario Di Luca; Cosetta Marchionni; Gualtiero Alvisi; Alessandro Ripalti
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

5.  Investigating the presence of human herpesvirus 7 and 8 in multiple sclerosis and normal control brain tissue.

Authors:  Margaret L Opsahl; Peter G E Kennedy
Journal:  J Neurol Sci       Date:  2005-10-20       Impact factor: 3.181

6.  DNA Sensors' Signaling in NK Cells During HHV-6A, HHV-6B and HHV-7 Infection.

Authors:  Daria Bortolotti; Valentina Gentili; Elisabetta Caselli; Mariangela Sicolo; Irene Soffritti; Maria D'Accolti; Isabel Barao; Antonella Rotola; Dario Di Luca; Roberta Rizzo
Journal:  Front Microbiol       Date:  2020-02-19       Impact factor: 5.640

7.  The P2X7 Receptor 489C>T Gain of Function Polymorphism Favors HHV-6A Infection and Associates With Female Idiopathic Infertility.

Authors:  Anna Pegoraro; Daria Bortolotti; Roberto Marci; Elisabetta Caselli; Simonetta Falzoni; Elena De Marchi; Francesco Di Virgilio; Roberta Rizzo; Elena Adinolfi
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.